Rebecca S Pettit

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Top Venues

Pediatric pulmonology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Riggsbee, Samantha Engdahl, Rebecca S Pettit
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatric pulmonology (2023)
Daniel Riggsbee, Samantha Engdahl, Rebecca S Pettit
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatric pulmonology (2023)
Daniel Riggsbee, Samantha Engdahl, Rebecca S Pettit
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatric pulmonology 58 (4) (2023)
Daniel Riggsbee, Samantha Engdahl, Rebecca S Pettit
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatric pulmonology 58 (4) (2023)
Daniel Riggsbee, Samantha Engdahl, Rebecca S Pettit
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients. Pediatric pulmonology 58 (4) (2023)
Taylor A Imburgia, Samantha R Engdahl, Rebecca S Pettit
Evaluation of the safety of cefepime prolonged infusions in pediatric patients with cystic fibrosis. Pediatric pulmonology 57 (4) (2022)
Tiffany E Burrus, Hilary Vogt, Rebecca S Pettit
Impact of a pharmacy technician and pharmacist on time to inhaled tobramycin therapy in a pediatric cystic fibrosis clinic. Pediatric pulmonology 56 (9) (2021)
Ashlee Anderson, Lindsey McCoy, Rebecca S Pettit, Brittany A Bruch, Lisa Lubsch
Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis. Pediatric pulmonology 56 (12) (2021)
Corinne A Muirhead, Wendy Palmrose, Michelle Condren, Shannon M Rotolo, Rebecca S Pettit, Mohsain Gill, Hanna Phan
A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis. Pediatric pulmonology 56 (9) (2021)